The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer
Abstract
BACKGROUND: Reproductive function following cancer treatment is of increasing importance with improving survival rates. We therefore assessed the markers of the ovarian reserve in premenopausal women, to investigate and compare the effects of chemotherapy and long-term gonadotrophin withdrawal on ovarian function. METHODS: Fifty premenopausal (age range 28-52 years) women with early breast cancer were recruited. Serum hormone and ovarian ultrasound measurements were taken before treatment and at intervals up to 1 year during chemotherapy or gonadotrophin suppressive therapy. RESULTS: Pretreatment samples indicated a fall in anti-Müllerian hormone (AMH) concentration with age before changes in other hormone concentrations. AMH concentration showed a rapid and marked fall during chemotherapy, with undetectable concentrations in many women (P<0.0001). Inhibin B concentration showed a lesser fall (P<0.0001), whereas estradiol (E2) concentrations were maintained. Both antral follicle count (AFC) and ovarian volume fell (P<0.0001 and P<0.05 respectively). Regimens containing taxanes in addition to cyclophosphamide showed increased gonadotoxicity. Gonadotrophin suppression resulted in expected falls in E2 (P<0.05) and inhibin B (P<0.001) levels, but also resulted in a delayed fall in AMH level after 6 months (P<0.0001). CONCLUSIONS: These data confirm the value of AMH concentration as an early indicator of ovarian ageing including assessment of chemotherapy-induced ovarian follicle loss. FSH and AMH concentration measurements may be useful for the comparison of ovarian toxicity of different chemotherapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
Faddy, M. J., Gosden, R. G., Gougeon, A., Richardson, S. J., & Nelson, J. F. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137570 · Cited by 1,365
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Measurement of dimeric inhibin B throughout the human menstrual cycle
Groome, N. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1401 · Cited by 946
Self-citationAntimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Self-citationAnti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/en.143.3.1076 · Cited by 843
Self-citationFertility preservation for young patients with cancer: who is at risk and what can be offered?
Wallace, W. H. B., Anderson, R. A., & Irvine, D. S. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70092-9 · Cited by 819
Self-citationOvarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Regulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L., Visser, J. A., & Themmen, A. P. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 779
Self-citationFanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
van Rooij, I. A. J., Broekmans, F. J. M., Scheffer, G. J., Looman, C. W. N., Habbema, J. D. F., de Jong, F. H., Fauser, B. J. C. M., Themmen, A. P. N., & te Velde, E. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.029 · Cited by 582
Self-citationFertility preservation in female patients
Sonmezer, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh021 · Cited by 496
Baarends, W. M., Uilenbroek, J. T., Kramer, P., Hoogerbrugge, J. W., van Leeuwen, E. C., Themmen, A. P., & Grootegoed, J. A. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588229 · Cited by 461
Self-citationGougeon, A., Ecochard, R., & Thalabard, J. C. (1994) · Biology of Reproduction · doi:10.1095/biolreprod50.3.653 · Cited by 456
Bancsi, L. F. J. M. M., Broekmans, F. J. M., Eijkemans, M. J. C., de Jong, F. H., Habbema, J. D. F., & te Velde, E. R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02983-1 · Cited by 441
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
Seifer, D. B., Lambert-Messerlian, G., Hogan, J. W., Gárdiner, A. C., Blazar, A. S., & Berk, C. A. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81865-1 · Cited by 325
Fanchin, R., Taieb, J., Lozano, D. H. M., Ducot, B., Frydman, R., & Bouyer, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh688 · Cited by 306
Pavlik, E. J., DePriest, P. D., Gallion, H. H., Ueland, F. R., Reedy, M. B., Kryscio, R. J., & van Nagell, J. R. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5783 · Cited by 292
Cytotoxic-lnduced Ovarian Failure in Women With Hodgkin's Disease: I. Hormone Function
Chapman, R. M. (1979) · JAMA · doi:10.1001/jama.1979.03300170023020 · Cited by 283
The effect of combination chemotherapy on ovarian function in women treated for hodgkin's disease
Whitehead, E., Shalet, S. M., Blackledge, G., Todd, I., Crowther, D., & Beardwell, C. G. (1983) · Cancer · doi:10.1002/1097-0142(19830915)52:6<988::aid-cncr2820520610>3.0.co;2-6 · Cited by 241
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
Scheffer, G. J. (2003) · Human Reproduction · doi:10.1093/humrep/deg135 · Cited by 215
La Marca, A., Malmusi, S., Giulini, S., Tamaro, L. F., Orvieto, R., Levratti, P., & Volpe, A. (2004) · Human Reproduction · doi:10.1093/humrep/deh508 · Cited by 191
Rl, S. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82652-7 · Cited by 159
Morphological study of the ovaries of leukaemic children
HIMELSTEIN-BRAW, R., Peters, H., & Faber, M. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.166 · Cited by 149
Wallace, E. M., Groome, N. P., Riley, S. C., Parker, A. C., & Wu, F. C. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4238 · Cited by 119
Self-citationYong, P. Y. K., Baird, D. T., Thong, K. J., McNeilly, A. S., & Anderson, R. A. (2003) · Human Reproduction · doi:10.1093/humrep/deg019 · Cited by 91
Self-citationRobertson, J. F. R., & Blamey, R. W. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00810-9 · Cited by 82
Brady, B. M., Walton, M., Hollow, N., Kicman, A. T., Baird, D. T., & Anderson, R. A. (2004) · Human Reproduction · doi:10.1093/humrep/deh491 · Cited by 54
Self-citationCampbell, B. K., Telfer, E. E., WEBB, R., & Baird, D. T. (2003) · Endocrinology · doi:10.1210/en.2003-1138 · Cited by 46
Cited by
Dewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Azim, A. A., Costantini-Ferrando, M., & Oktay, K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8700 · Cited by 480
How do chemotherapeutic agents damage the ovary?
Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms022 · Cited by 409
Self-citationAnti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Fertility Preservation in Adolescents and Young Adults With Cancer
Levine, J., Canada, A., & Stern, C. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8312 · Cited by 323
Metadata
- Authors
- Anderson, R. A., Themmen, A. P. N., -Qahtani, A. A., Groome, N. P., & Cameron, D. A.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-04
- Volume
- 21
- Issue
- 10
- Pages
- 2583-2592
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2158380191
- Cited by
- 365
- References
- 33
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.